| Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
|---|
| 07/11/2007 | CN1325449C Compound for organic el element and organic el element |
| 07/10/2007 | US7241921 hydroxamic acid and N-formyl hydroxylamine compounds which inhibit the activity of the bacterial enzyme known as peptide deformylase |
| 07/10/2007 | US7241896 High yield amidation in water and water immiscible organic solvent without use of auxilary base; stability; industrual scale |
| 07/10/2007 | US7241811 Amide compounds for the potentiation of cholinergic activity |
| 07/10/2007 | US7241810 For therapy of inflammatory, allergic and respiratory diseases |
| 07/10/2007 | US7241789 Substituted indoles and their use as integrin antagonists |
| 07/10/2007 | US7241782 Modifications are prepared by subjecting an alkaline solution of torasemide to a rapid acidification with inorganic or organic acids at 0 to 35 degrees C. |
| 07/10/2007 | US7241780 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| 07/10/2007 | US7241778 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety |
| 07/10/2007 | US7241765 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues |
| 07/10/2007 | US7241764 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders |
| 07/10/2007 | US7241758 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases |
| 07/10/2007 | US7241721 carboxamide derivatives as active ingredients which have microbiocidal activity, in particular fungicidal activity |
| 07/10/2007 | US7241715 Dianionic chelating ligands with a bridged-bis-bi-aryl structure; For catalytic polymerization of ethylene/olefin copolymers |
| 07/10/2007 | CA2549561C 36- derivatives of rifamycins |
| 07/05/2007 | WO2007076473A2 Substituted pyrimidinyloxy ureas useful as inhibitors of protein kinases |
| 07/05/2007 | WO2007076104A1 Vanilloid receptor ligands and their use in treatments |
| 07/05/2007 | WO2007075688A2 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | WO2007075534A2 Polymer conjugates of glp-1 |
| 07/05/2007 | WO2007075194A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | WO2007074871A1 Novel cxcr4 antagonist and use thereof |
| 07/05/2007 | WO2007074789A1 1,3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof |
| 07/05/2007 | WO2007074753A1 Pharmaceutical comprising substituted urea derivative |
| 07/05/2007 | WO2007073935A1 Heterocyclic compounds |
| 07/05/2007 | WO2007073934A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/05/2007 | WO2006067466A3 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 07/05/2007 | US20070155839 4-[(4-Hydroxyphenyl)(3,3,5,5-tetramethylcyclohexylidene) methyl]benzoic acid; selective estrogen receptor modulation; SERMS |
| 07/05/2007 | US20070155813 Such as methyl 3,5-dihydroxy-2-phenylphenylacetate; antitumor activity; leukemia, multiple myeloma, lymphoma; heat shock protein 90 (Hsp90) suppression |
| 07/05/2007 | US20070155801 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 07/05/2007 | US20070155790 Meta-benzamidine derivatives as serine protease inhibitors |
| 07/05/2007 | US20070155785 Hydroxamic acid compounds and methods of use thereof |
| 07/05/2007 | US20070155756 Treatment of chemokine mediated diseases |
| 07/05/2007 | US20070155748 N-sulfonyl-alpha-amino-acid derivatives |
| 07/05/2007 | US20070155745 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina |
| 07/05/2007 | US20070155724 Methods of Treating Cytokine Mediated Diseases |
| 07/05/2007 | US20070155671 e.g. N-[2-chloro-4-[[[(3-hydroxyphenyl)methyl]amino]carbonyl]benzoyl]-3-(phenylmethyl)amino-L-alanine; intercellular adhesion molecules blocking agent; antiinflammatory; reperfusion injury following acute myocardial infarction |
| 07/05/2007 | US20070155657 Hypoglycemic agent |
| 07/05/2007 | US20070155656 Hypoglycemic agent |
| 07/05/2007 | US20070155655 Zinc (vitamin C)2 complex; low toxicity; insulin mimetics; stability; fat soluble; diabetes |
| 07/05/2007 | DE102005062985A1 Substituierte bis(hetero)aromatische N-Ethylpropiolamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted bis (hetero) aromatic N-Ethylpropiolamide and their use for the preparation of medicaments |
| 07/05/2007 | CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors |
| 07/05/2007 | CA2634847A1 Substituted aniline derivatives useful as histamine h3 antagonists |
| 07/05/2007 | CA2634833A1 Pyridinyl amine derivatives as inhibitors of cholesteryl ester transfer protein (cetp) |
| 07/04/2007 | EP1802618A1 Biphenyl integrin antagonists |
| 07/04/2007 | EP1802580A2 Pyridine derivatives |
| 07/04/2007 | EP1802579A1 3-arylamino pyridine derivatives |
| 07/04/2007 | EP1802578A1 3,6-substituted 5-arylamino-1h-pyidine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease caused by necrosis or apoptosis |
| 07/04/2007 | EP1802577A1 Indane amides with antiproliferative activity |
| 07/04/2007 | EP1802570A1 Process for making phenoxy benzamide compounds |
| 07/04/2007 | CN1993340A Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression |
| 07/04/2007 | CN1993339A Aromatic compounds |
| 07/04/2007 | CN1993327A 3-Carbamoyl-2-pyridone derivative |
| 07/04/2007 | CN1993326A Heterocyclic acetophenone potentiators of metabotropic glutamate receptors |
| 07/04/2007 | CN1990477A Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| 07/04/2007 | CN1990457A 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 07/04/2007 | CN1989969A Cyclic protein tyrosine kinase inhibitors |
| 07/04/2007 | CN1324015C Pyridine and pyrimidine derivatives |
| 07/04/2007 | CN1324012C TNF-alpha prodn. inhibitors |
| 07/04/2007 | CN1324001C Novel thyroid receptor ligands |
| 07/03/2007 | US7238764 Process for the co-oligomerisation of ethylene and alpha olefins |
| 07/03/2007 | US7238717 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis. |
| 07/03/2007 | US7238714 Analgesics; antiinflammatory agents; antiarthritic agents |
| 07/03/2007 | US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders |
| 07/03/2007 | US7238211 E.g., 2-[(3-amino-6-methoxy-2-pyridyl)methylamino]ethanol; these couplers give strong colorations in varied shades that are uniform from the root to the end of the hairs, that show little selectivity and particularly good resistance, and that have good chromaticity |
| 07/03/2007 | CA2219655C Process for the catalytic hydrogenation of aromatic nitro compounds |
| 06/28/2007 | WO2007072970A1 Compound, photoelectric converter and photoelectrochemical cell |
| 06/28/2007 | WO2007072869A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | WO2007072868A1 Crystal of 1,2-dihydropyridine compound (type iv) |
| 06/28/2007 | WO2007072782A1 Carboxylic acid derivative or salt thereof |
| 06/28/2007 | WO2007072742A1 Compound and organic light-emitting device |
| 06/28/2007 | WO2007072092A2 New phenanthridine derivatives as bradykinin antagonists |
| 06/28/2007 | WO2007072089A1 Mglur5 antagonistic carbamoyl-oxime derivatives |
| 06/28/2007 | WO2007071961A1 Benzamide derivatives |
| 06/28/2007 | WO2007071956A1 Novel benzamide derivatives |
| 06/28/2007 | WO2007071900A1 Novel herbicides |
| 06/28/2007 | WO2007071792A1 Sensitizing complexes, their method of production, hybrid inorganic/ organic semiconductor material comprising them, and photovoltaic cell comprising this material |
| 06/28/2007 | WO2007071766A2 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | WO2007071609A1 Malononitrile compounds |
| 06/28/2007 | WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/28/2007 | WO2007071311A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3 |
| 06/28/2007 | WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents |
| 06/28/2007 | WO2007026920A3 Amide derivatives as rock inhibitors |
| 06/28/2007 | US20070149608 3-(4-Benzyloxyphenyl) propanoic acid derivatives |
| 06/28/2007 | US20070149577 Compounds with medicinal effects due to interaction with the glucocorticoid receptor |
| 06/28/2007 | US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity |
| 06/28/2007 | US20070149516 to treat cellular proliferative diseases, hyperplasias, solid tumor, cardiac hypertrophy, immune disorders and inflammation; modulators of one or more mitotic kinesins; N-(2-(2-dimethylamino-acetylamino)-1-{4-[8-(1-hydroxy-ethyl)-imidazo[1,2-a]pyridin-2-yl]-benzyl}-ethyl)-3-chloro-4-isopropoxy-benzamide |
| 06/28/2007 | US20070145888 Aromatic amine derivatives and organic electroluminescence device using the same |
| 06/28/2007 | CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 06/28/2007 | CA2634601A1 Malononitrile compounds |
| 06/28/2007 | CA2634056A1 Amorphous form of 1,2-dihydropyridine compound |
| 06/28/2007 | CA2631390A1 Phenoxy acetic acids as ppar delta activators |
| 06/28/2007 | CA2631145A1 Novel herbicides |
| 06/28/2007 | CA2629065A1 2 -phenylethylamino derivatives as calcium and/or sodium channel modulators |
| 06/28/2007 | CA2627630A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors |
| 06/27/2007 | EP1801103A1 Preparation of 2-((2,3- dihydro-benzo(1,4) dioxin-5-YL)-(2-hydroxyethyl)-amino)-ethanol and related intermediates |
| 06/27/2007 | EP1801102A1 Process for production of 2-hydroxy-4-substituted pyridines |
| 06/27/2007 | EP1801100A1 Functional trithiocarbonate RAFT agents |
| 06/27/2007 | EP1801098A1 2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors |
| 06/27/2007 | EP1799658A2 Modulators of crth2 rezeptor activity for the treatment of prostaglandin d2 mediated diseases |